AUGTYRO: payments to doctors
Payments that named AUGTYRO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $136K
- Providers
- 753
- Transactions
- 1,063
- Average per transaction
- $128
The per-transaction average — $128 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 753 providers the average total is $181, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $136,217 | 100.0% |
| Bristol Myers Squibb | $36 | 0.0% |